Contracts Finder

NHS National Generic Pharmaceuticals Wave 14b

Atamis LTD

Awarded

goods

SME-friendly

Framework agreement

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from Atamis LTD, and hundreds more across the UK public sector.

Key details

Contracting authority

Atamis LTD

other

Region

Runcorn

Sector

Healthcare & Medical

Contract value

£428,226,984ex VAT

Submissions closed

18 April 2023

Published

16 August 2023

Procurement

Contract period

1 October 2023 - 30 September 2025

2 years

Procedure type

Open procedure (above threshold)

CPV classifications

33600000 Pharmaceutical products

What happened

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 14b

Offer reference number: CM/PHG/22/5668

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.

Potential periods of call-offs under the framework agreement:

Orals (plus non-parenteral) Products All regions 01/10/2023 to 31/05/2024 (8months)

Hospital Only Products: DCE & DSW regions 01/10/2023 - 30/09/2025 (24 months)

Housekeeping Products (Hospital Only):

DLN & DNW regions 01/10/2023 -31/01/2025 (16 months)

DLS & DNE regions 01/10/2023 - 31/05/2024 (8 months)

Awarded suppliers (99)

Suppliers

Aspen Pharmacare UK Limited
Flexipharm Austrading Limited
Laboratorio Reig Jofre SA
Colonis Pharma Ltd
Consilient Health Ltd
hameln pharma ltd
Galvany Pharma Ltd
Piramal Critical care Limited
Martindale Pharma
Fresenius Kabi Limited
Amarox Limited
Sandoz Ltd
Lundbeck Limited
Pfizer Ltd
Stirling Anglian Pharmaceuticals Ltd
Lucane Pharma
GlaxoSmithKline UK Limited
Wockhardt UK Limited
Kent Pharma Ltd
Morningside Pharmaeuticals
Arcadia Pharma Ltd T/A Arcadia Medical
Thornton and Ross Ltd
Milpharm Ltd/aurobinbdo
Accord-UK Ltd
Bowmed Ibisqus Limited
Mylan
B. Braun Medical Limited
Thea Pharmaceuticals Limited
Neuraxpharm UK Ltd
Biocon
Esteve Pharmaceuticals Ltd
Manx Healthcare Ltd
CST Pharma Limited
Janssen-Cilag Ltd
P M Pharma
PARI
Otsuka Pharmaceuticals UK Limited
Ferring Pharmaceuticals Ltd
Teva UK Limited
Bristol Laboratories Limited
Dr.Reddy's Laboratories (UK) Limited
Selective Supplies Ltd.
Day Lewis Medical Ltd
Bayer Plc
Sun Pharma UK Ltd
FLYNN PHARMA LTD
Glenmark Pharmaceuticals Europe Limited
MSN Laboratories Europe Limited
Aventis Pharma ltd t/a Sanofi
Chiesi Limited
Gerot Lannach UK Ltd
Lupin Healthcare (UK) Limited
medac Pharma LLP
Recordati Pharmaceuticals Ltd
Relonchem Ltd
Baxter Healthcare Ltd
Zentiva Pharma UK Ltd
Mercury Pharmaceuticals Limited
Macure Pharma ApS
AGB Pharma
Aspire Pharma Limited
Aguettant Ltd
Alturix
Beaumont Pharma Ltd
Panpharma UK Limited
Cipla
Roma Pharmaceuticals Limited
Roche Products Ltd
Ridge Pharma
MIP Pharma GmbH
Takeda UK Ltd
Novartis Pharmaceuticals UK Ltd
Norgine Pharmaceuticals Limited
ROVI Biotech Ltd
Bristol Myers Squibb
Perennial Pharma Ltd
Ascend Laboratories UK Ltd
Zista Pharma Ltd
Brown & Burk UK Ltd
Torbay Pharmaceuticals
Synchrony
Almirall
Tillomed Laboratories ltd
Seacross Pharmaceuticals Ltd
Syri Limited (T/A Thame Laboratories)
RPH Pharmaceuticals AB
Tetris Pharma Lts
GH Pharma Ltd
Sintetica Ltd
GENNISIUM PHARMA
Phoenix Lab
Crescent Pharma Ltd
Kyowa Kirin Ltd
Typharm Ltd
Vantage Pharmaceuticals Ltd
Bausch + Lomb (Pharma)
JCSH Pharma Ltd
Brancaster Pharma Ltd
Waymade PLC

Award value

£428,226,984

Award date

7 July 2023

Contact

Address

2nd Floor, Rutland House, Runcorn, WA7 2ES

Contact name

David Ford

[email protected]

Identifiers

Buyer reference

CF-1768400D0O000000rwimUAA

Notice ID

e60c1acf-3d75-4bad-b3c5-d45f289254d5-672388

OCID

ocds-b5fd17-b1081409-5829-4aeb-8bff-5dbf01e70c26

Explore related tenders

External ID: cf-ocds-b5fd17-b1081409-5829-4aeb-8bff-5dbf01e70c26 • Added 4 October 2026